↑  Read the latest from the desks  ·  fresh intelligence, published daily✦Quiet reading✦No ads, ever

✦Corporate brand & media services✦Made in Virginia Beach since 1997✦

Viemed Healthcare: New ship (no warning signs)New ship

Viemed Healthcare $VMD

Grew revenue 20.5% in FY2025 to $270 million, operating margin 8.5% against a 2.0% median for misc health & allied services, equity 71.1% of assets.

Last filing10-Q, 4 Nov 2026

Next year, 80%$285M–$370M
Growth, on the year20.5%
Operating margin8.5%
Equity of assets71.1%
Credibility50%
Track record4 of 4
Your call, sealedNext year’s revenue, your range. Sealed now, graded when the annual report lands.
Edgarette’s full reading · exposure, experience, soundness, credibility, range

🫧 Edgar looked up Viemed Healthcare, Inc. ($VMD). Last filing: 10-Q, 2026-11-04. 8 event filings (8-K) in the past twelve months.

🔖 Exposure: revenue $270.3M (FY2025), total debt $12.4M. Experience: revenue up 20.5% on the year, up 23.3% a year over 4 years; operating margin 8.5%, up from 8.0%. Soundness: equity 71.1% of assets, return on equity 10.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $285.2M and $370.1M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $267.0M to $396.4M. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): operating margin 8.5% against a 2.0% median; growth 20.5% against 13.0%.

Read from its own SEC filings · nothing written, nothing inferred

Viemed Healthcare, Inc. against its own record and its peers
Operating marginPeer median 2.0%8.5%Revenue, on the yearPeer median 13.0%20.5%Equity of assetsPeer median 44.2%71.1%Return on equityPeer median 1.6%10.9%Gold tick: the median of 49–59 peers with $50M+ revenue in services-misc health & allied services, nec

Speed and cash · fiscal 2025

Cash Compass🌱 Cash cow later · growing fast, and already turning revenue into cash
Inside viewTurns 19.2% of revenue into operating cash; revenue growing 24.9% a year over three years; no common dividend.
Outside viewAmong $100M-1B companies: 71st percentile for cash, 82nd for growth. cash growth

Both views must agree for a label · a description, not advice.

Cash flow (op · inv · fin · free)$52M · −$50M · −$6M · $12M
Investment book (cash · short · long)$14M · — · — · current ratio 1.18
Revenue swing · equity of assets4.7% · 71.1%

Viemed Healthcare is growing faster than its size class, with steadier revenue. Its own audited SEC figures.

The figures, as filed

Fiscal year end2025-12-31
Revenue$270M
Revenue, on the year20.5%
Revenue, a year over the record23.3%
Operating margin8.5%
Operating margin, prior year8.0%
Net margin5.7%
Research and development$3M · 1.1% of revenue
Total debt$12M
Equity of assets71.1%
Return on equity10.9%
Payout of profit—
Dividend per share—
Earnings per share$0.38
Book value per share$3.47
Revenue per share$6.62
Shares outstanding40,823,823
Audited years read5

Peers: the median of 54 filers with $50M+ revenue in services-misc health & allied services, nec.

Classic signals · fiscal 2025Altman Z″ 5.38 safe zone 1968Piotroski F 6 of 9 solid 2000Beneish M -3.18 below the −1.78 line 1999Sloan accruals -19.4% earnings backed by cash 1996DuPont ROE 11.3% = margin 5.7% × turns 1.44 × leverage 1.38

What a terminal subscription used to buy, a filing and arithmetic now give anyone. Published method, from the same filings. Display only: nothing here moves the range or its receipt. Why? →

Health HarborViemed Healthcare sails as New shipno warning signs

Health watch · 12 monthsDirector or officer change

Versus peersoperating margin 8.5% vs a 2.0% median · revenue growth 20.5% vs 13.0% · cash beats 71% of its size class · growth beats 82% 54 services-misc health & allied services, nec filers

Trend · last year to this▲operating margin 8.0% → 8.5% · ▲revenue $224.3M → $270.3M · 5-year revenue: $117.1M · $138.8M · $183.0M · $224.3M · $270.3M

See all 24 services-misc health & allied services, nec companies on POPS4 sorted from the newest ship to the boat at the dock
#CompanyConditionOperating marginRevenue growthSales
1New shipTenet HealthcareTHCNew ship16.5%3.1%$21.3B
2New shipConcentra Group Holdings ParentCONNew ship15.4%13.9%$2.2B
3New shipSurgery PartnersSGRYNew ship11.8%6.2%$3.3B
4New shipAveanna Healthcare HoldingsAVAHNew ship10.5%20.2%$2.4B
5New shipAddus HomeCareADUSNew ship9.7%23.2%$1.4B
6New shipOption Care HealthOPCHNew ship6.0%13.0%$5.6B
7New shipHims & Hers HealthHIMSNew ship4.5%59.0%$2.3B
8New shipArdent HealthARDTNew ship—6.0%$6.3B
9New shipHealthcare Services GroupHCSGNew ship—7.1%$1.8B
10Sound shipPacs GroupPACSSound ship5.9%29.3%$5.3B
11Sound shipAdaptHealthAHCOSound ship2.8%−0.5%$3.2B
12Sound shipTeladoc HealthTDOCSound ship−10.4%−1.5%$2.5B
13Sound shipSonida Senior LivingSNDASound ship—25.2%$381.1M
14Sound shipHca HealthcareHCASound ship—7.1%$75.6B
15Weathered boatCardiff LexingtonCDIXWeathered boat9.5%39.5%$11.5M
16Weathered boatCryo-Cell InternationalCCELWeathered boat1.5%−1.3%$31.6M
17Weathered boatLifemdLFMDWeathered boat−4.0%25.3%$194.1M
18Old boatAirSculpt TechnologiesAIRSOld boat−7.6%−15.8%$151.8M
19Rotting at the dockStarling OncologySTLNRotting at the dock−7.2%27.8%$502.7M
20Rotting at the dockMarpaiMRAIRotting at the dock−74.9%−35.8%$18.1M
21Rotting at the dockBioCorRxBICXRotting at the dock−606.0%10301.1%$0.8M
22Rotting at the dockMangoceuticalsMGRXRotting at the dock−3954.3%−26.0%$0.5M
23Rotting at the dockBiorestorative TherapiesBRTXRotting at the dock−4350.1%−10.3%$0.4M
24Rotting at the dockEdgemodeEDGMRotting at the dock——$0.0M

From each company’s own POPS4 card. Green beats the industry median above, red trails it. Not a rating and not investment advice.

Sailing speed follows growth: 24.9% a year crosses the harbor in 30 seconds.

🌊 Visit the Bay →

No warning signs on the measures below.

Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an operating loss; negative free cash flow outside regulated utilities; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.

Brand success factors · calendar 2025

The Trillion Score: 519

Exponential Success Score

Built on over $200 trillion of sworn revenue, 13 years of data, 770,002 figures. Sealed by Edgarette.

How The Trillion Score works. We read eight measures of success from Viemed Healthcare's own SEC filings and test each one against the public companies in its field, here other health & allied services. The longer and fuller the record, the more weight those results carry. A model built on past filings then turns them into the odds of thriving, which means outgrowing the field for three years without a severe decline. A score of 500 is about average, and every 100 points doubles the odds. Every company is ranked on this same scale.

What it says here. At 519, Viemed Healthcare's odds of thriving come to 40%, against about 37% for the typical filer. It meets 5 of 8 success points.

519The Trillion Score
40%modeled odds of thriving over three years
MediumFall Risk
#1 of 7rank in its field
#1,085 of 2,824rank across all filers

What the score means

The higher the score, the more often companies went on to thrive. At this level, about 38 of every 100 did.

31%Under 45035%450 to 49938%500 to 549This company: 51944%550 to 59957%600 and up

Share of companies that beat their field for three years with no severe decline, tested on 2019 to 2022 filings.

Fall Risk: Medium

Separate from the score, this asks what could go wrong: the odds of sales falling 30% or the filings stopping within three years. In the tests, about 22 of every 100 companies in the Medium band did. That is the group's history, not a forecast for this company.

MoneyIt keeps about 4 cents of free cash from each sales dollar after paying for its plants and equipment. It holds more cash than debt.moderate
SwingsIn its worst fifth of years, sales fell about 12% a year.-11.5% a year
Filed eventsIn the last two years it told the SEC about 3 filings on leadership or auditor changes.3

The eight success points

PointWhat it meansPlace in field
SpeedSales grew faster than most of its field.88 of 100Met
SteadinessGrowth swung a lot for what it delivered.29 of 100Not yet
Price premiumIt keeps more of each sales dollar than most of its field.75 of 100Met
Margin stays above the fieldIts margin has held above the field year after year.100 of 100Met
Moat half-lifeIts margin edge is fading slowly, if at all.67 of 100Met
Brand spend yieldBrand spending returns less gross profit than for the leaders in its field.33 of 100Not yet
Learning curveCosts have not fallen much as a share of sales as it grew.0 of 100Not yet
Climb in the fieldIt has been moving up the size ranks in its field.50 of 100Met

Price premium $6M is the extra gross profit over a field-median margin. Momentum $23M is gross profit times growth above the field's pace.

The actuarial view

CredibilityWith 8 years of filings, the record earns 70% of the weight. The rest stays at the middle of the field.0.70
Severe decline, class BAbout 26 of every 100 companies with this many points fell 30% or stopped reporting within three years.26.1%
Actual vs expectedSales are 55% higher than if it had simply kept pace with its field.1.55

Top of its field: #1 Viemed Healthcare · #2 agilon health · #3 Cryo Cell International · #4 Davita · #5 Sotera Health

Ranked by The Trillion Score. See the method and score your own brand. Tested on 2019 to 2022 filings. Odds, class and Fall Risk figures are the experience of similar filers, not a forecast for this company. A statistical description of past filings, not a rating or advice.

Recent filings
Measured, not prophesiedSuccess tools: score it, compare it, see its fieldFour questions. Scored against the SEC filings of the companies in your field.

Try InstagramSpriteHokaDisneyGatoradee.l.f.

Each benchmark is the median of SEC filers in your industry code, from their own audited filings, read on the filing boards. Reporting, not investment advice.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · Open in Excel (CSV) · Ten-year table (CSV) ·

1 · Follow

Follow their filings

Or tap watch on any row above. You get the company’s live filing feed and Edgar’s card. Nothing to sign up for.

On Bluesky: follow Edgar & Edgarette.

2 · Price it

A new leader’s rebrand and launch

Priced live by the same engine as our estimator, from the catalogue at wholesale.

Price the printing · Open the full estimator

✦ Build the kit yourself
3 · Confirm

Check it with Jenny

Most buyers check what they found, or what their AI found, with one person before they commit. That person is the principal.

Jenny Huang Goodman MPA MSc MHSA, Principal

Book a time info@pops4.com
Independence. Every range, flag and score on these boards is identical for everyone. Clients of POPS4 or Hako Shikin receive no different numbers, no earlier access and no say in what is published. The service lines shown beside each board describe work we do; they never change the data. For reviewers: Method · Terms of use · Status
Free · unsponsored · source-linked

Clean data. No ads. Not now, not later.

Nine boards reading every SEC filing the business day after it lands, from the settled SEC daily index, ten editorial desks publishing daily, an open endpoint other AIs can query, and a 70,000-product house behind all of it. This is the public record end of it.

Every row is a filing.Straight from the company's own SEC document, linked. Nothing written, nothing inferred.
Nobody is watching you read.No ad trackers, no cookies from us. Our page counts are cookieless.
One email, one job.Watch a company and we hold that address for the alert alone. One tap ends it. Never shared, never passed on.
The house pays for this.Corporate event programs, corporate supplies and branded merchandise, since 1997. That is what funds the desks, under the house's own vendor standards.
Free to reuse with credit · CC BY 4.0 · how the boards are built
Data & Disclosure Notice: Edgar and Edgarette are automated software. Every figure on this page is calculated by software from public filings made by companies and funds with the U.S. Securities and Exchange Commission (EDGAR) and is published without individual human review. The accuracy and completeness of those filings are the responsibility of the filers; reports can contain errors and can be amended. Figures are shown as filed and as of each filing's date, and this page may be corrected or updated without notice. Ranges, expected returns, rankings, boats and other measures are statistical descriptions of past filings, not ratings, price forecasts, company guidance or recommendations; past results do not guarantee future results. This is general information published for all readers, not advice tailored to any person's portfolio, needs or circumstances, and nothing here is financial, investment, actuarial, legal, tax or other professional advice. Actuaries and other professionals who use these figures remain responsible for reviewing them for reasonableness and consistency against the original filings and for disclosing their reliance on them. No company, fund or reinsurer pays to be included or ranked. Provided as is, without warranty of any kind. Not affiliated with or endorsed by the SEC or by any company, fund or reinsurer named. All trademarks remain the property of their owners.